Tiwari Swasti, Halagappa Veerendra K M, Riazi Shahla, Hu Xinqun, Ecelbarger Carolyn A
Department of Medicine, Georgetown University, Box 571412, Washington, DC 20057-1412, USA.
J Am Soc Nephrol. 2007 Oct;18(10):2661-71. doi: 10.1681/ASN.2006121410. Epub 2007 Sep 12.
Insulin resistance is accompanied by hyperinsulinemia and activation of the renin-angiotensin system, both of which are associated with hypertension. Because the kidney plays a major role in the regulation of blood pressure, we studied the regulation of insulin receptor expression in the kidney during states of insulin resistance. Using two rat models of insulin resistance, Western blot analysis demonstrated a significant reduction in the expression of insulin receptor subunits in the kidney compared to lean control rats. Treatment of insulin resistance in Zucker rats with the insulin-sensitizing drug rosiglitazone partially restored renal insulin receptor levels. Conversely, treatment with the angiotensin II type 1 receptor (AT1) antagonist candesartan increased renal insulin receptor expression compared to untreated rats. Streptozotocin-induced hyperglycemia, which results from hypoinsulinemia, reduced expression of renal insulin receptors. Hyperinsulinemia induced by insulin infusion, however, did not produce a similar effect. In conclusion, insulin receptors are downregulated in the kidneys of insulin resistant rats, possibly mediated by hyperglycemia and angiotensin II.
胰岛素抵抗伴有高胰岛素血症和肾素 - 血管紧张素系统激活,这两者均与高血压相关。由于肾脏在血压调节中起主要作用,我们研究了胰岛素抵抗状态下肾脏中胰岛素受体表达的调节。使用两种胰岛素抵抗大鼠模型,蛋白质免疫印迹分析表明,与瘦对照大鼠相比,肾脏中胰岛素受体亚基的表达显著降低。用胰岛素增敏药物罗格列酮治疗 Zucker 大鼠的胰岛素抵抗可部分恢复肾脏胰岛素受体水平。相反,与未治疗的大鼠相比,用 1 型血管紧张素 II 受体(AT1)拮抗剂坎地沙坦治疗可增加肾脏胰岛素受体表达。链脲佐菌素诱导的高血糖症由低胰岛素血症引起,降低了肾脏胰岛素受体的表达。然而,胰岛素输注诱导的高胰岛素血症并未产生类似的效果。总之,胰岛素抵抗大鼠肾脏中的胰岛素受体下调,可能由高血糖症和血管紧张素 II 介导。